BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wareham LK, Risner ML, Calkins DJ. Protect, Repair, and Regenerate: Towards Restoring Vision in Glaucoma. Curr Ophthalmol Rep 2020;8:301-10. [PMID: 33269115 DOI: 10.1007/s40135-020-00259-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Pérez Y, Bonet R, Corredor M, Domingo C, Moure A, Messeguer À, Bujons J, Alfonso I. Semaphorin 3A-Glycosaminoglycans Interaction as Therapeutic Target for Axonal Regeneration. Pharmaceuticals (Basel) 2021;14:906. [PMID: 34577606 DOI: 10.3390/ph14090906] [Reference Citation Analysis]
2 Mohana Devi S, Abishek Kumar B, Mahalaxmi I, Balachandar V. Leber's hereditary optic neuropathy: Current approaches and future perspectives on Mesenchymal stem cell-mediated rescue. Mitochondrion 2021;60:201-18. [PMID: 34454075 DOI: 10.1016/j.mito.2021.08.013] [Reference Citation Analysis]
3 Ribeiro M, McGrady NR, Baratta RO, Del Buono BJ, Schlumpf E, Calkins DJ. Intraocular Delivery of a Collagen Mimetic Peptide Repairs Retinal Ganglion Cell Axons in Chronic and Acute Injury Models. Int J Mol Sci 2022;23:2911. [PMID: 35328332 DOI: 10.3390/ijms23062911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Martinez Velazquez LA, Ballios BG. The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease. Int J Mol Sci 2021;22:11542. [PMID: 34768969 DOI: 10.3390/ijms222111542] [Reference Citation Analysis]
5 Rahić O, Tucak A, Omerović N, Sirbubalo M, Hindija L, Hadžiabdić J, Vranić E. Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions. Pharmaceutics 2020;13:E28. [PMID: 33375224 DOI: 10.3390/pharmaceutics13010028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Porciatti V, Chou TH. Modeling Retinal Ganglion Cell Dysfunction in Optic Neuropathies. Cells 2021;10:1398. [PMID: 34198840 DOI: 10.3390/cells10061398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Risner ML, Pasini S, McGrady NR, D'Alessandro KB, Yao V, Cooper ML, Calkins DJ. Neuroprotection by WldS depends on retinal ganglion cell type and age in glaucoma. Mol Neurodegener 2021;16:36. [PMID: 34090501 DOI: 10.1186/s13024-021-00459-y] [Reference Citation Analysis]
8 McGrady NR, Pasini S, Baratta RO, Del Buono BJ, Schlumpf E, Calkins DJ. Restoring the Extracellular Matrix: A Neuroprotective Role for Collagen Mimetic Peptides in Experimental Glaucoma. Front Pharmacol 2021;12:764709. [PMID: 34795592 DOI: 10.3389/fphar.2021.764709] [Reference Citation Analysis]
9 Risner ML, Pasini S, Chamling X, McGrady NR, Goldberg JL, Zack DJ, Calkins DJ. Intrinsic Morphologic and Physiologic Development of Human Derived Retinal Ganglion Cells In Vitro. Transl Vis Sci Technol 2021;10:1. [PMID: 34383881 DOI: 10.1167/tvst.10.10.1] [Reference Citation Analysis]
10 Estera LA, Walsh SP, Headen JA, Williamson RE, Kalinski AL. Neuroinflammation: Breaking barriers and bridging gaps. Neurosci Res 2021:S0168-0102(21)00222-4. [PMID: 34748905 DOI: 10.1016/j.neures.2021.11.001] [Reference Citation Analysis]
11 García-Bermúdez MY, Freude KK, Mouhammad ZA, van Wijngaarden P, Martin KK, Kolko M. Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets. Front Neurol 2021;12:624983. [PMID: 33796062 DOI: 10.3389/fneur.2021.624983] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]